Peer review reports
From: Binimetinib inhibits MEK and is effective against neuroblastoma tumor cells with low NF1 expression
Original Submission | ||
---|---|---|
2 Oct 2015 | Submitted | Original manuscript |
30 Nov 2015 | Reviewed | Reviewer Report - NISSAR Ahmad Wani |
2 Dec 2015 | Reviewed | Reviewer Report - Ram Lakhan |
4 Feb 2016 | Author responded | Author comments - Sarah Woodfield |
Resubmission - Version 2 | ||
4 Feb 2016 | Submitted | Manuscript version 2 |
Publishing | ||
17 Feb 2016 | Editorially accepted | |
1 Mar 2016 | Article published | 10.1186/s12885-016-2199-z |